Musculoskeletal Disorders (MSDs) are both common and costly. In fact, MSDs are the single largest category of workplace injuries and are responsible for almost 30 percent of all workers’ compensation costs
HR leaders need to coordinate on their P&Ps, best practices while collaborating with other executives around managing all risks. Vendors and healthcare supply chains serving the workplace need more collaboration as part of managing all risks related to this pandemic event.
Key Healthcare Trends for 2020 and Beyond was published earlier this year. The following is some thoughts on the impact that Covid-19 will have on employers and other industry stakeholders.
The healthcare marketplace is undergoing fast-paced changes fueled by political and regulatory events, medical, pharmaceutical and technology advancements, consumerism, and growing payer engagement in value-based reimbursement and contracting.
Closing Gaps in Health Plan Performance with Stakeholder Collaboration Published in American Health & Drug Benefits, October 2015, Vol 8, No 7, Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment F. Randy Vogenberg, PhD, RPh, Partner, Access Market Intelligence Employers/Health Plans: For most commercial health plans and employer-sponsored health plans, immunology represents a […]
Planning a Specialty Drug Strategy Through 2020 – Traditional approaches are not suited to managing the cost of specialty drug therapies By Gregory Judd, CEBS, and Randy Vogenberg, PhD 5/4/2015 (originally published by Society for Human Resource Management (SHRM)) The specialty drug tsunami is picking up strength and is about to come crashing down on […]